🇺🇸 FDA
Pipeline program

metformin

1218.83

Approved small_molecule completed

Quick answer

metformin for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim
Indication
Diabetes Mellitus, Type 2
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials